[Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy].
Alioune Camara(Donka Hospital), C. Françès(Navarre Institute of Health Research), PA Bécherel(Hôpital Saint-Louis), O. Chosidow(Sorbonne Université), S. Lagrange(Université Paris 1 Panthéon-Sorbonne), A Bussel, Piette Jc, P. Joly(Inserm)
PubMed
November 9, 1999
Cited by 23
Related Papers
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
|New England Journal of Medicine|2018|392
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332